Pyrene-substituted polyhydromethylsiloxanes (PHMS-Py x ) were synthesised by the hydrosilylation reaction of prop-3-enyloxymethylpyrene with polyhydromethylsiloxane (M n ¼ 3700). The ratio of pyrene substituent to Si-H unit was varied to afford a range of pyrene-functionalised polysiloxanes. These copolymers were subsequently incorporated into polydimethylsiloxane (PDMS) elastomers by curing via either Pt(0) catalysed hydrosilylation with divinyl-terminated PDMS (M n ¼ 186) and tetrakis(dimethylsiloxy)silane, or Sn(II) catalysed condensation with a,u-dihydroxyPDMS (M n ¼ 26 000) and tetraethoxysilane. An alternative method involving the synthesis and integration of [3-(pyren-1-ylmethoxy)propyl]triethoxysilane (Py-TEOS) into PDMS elastomers was also investigated: a mixture of a,u-dihydroxyPDMS (M n ¼ 26 000), tetraethoxysilane, and Py-TEOS was cured using an Sn(II) catalyst. Certain of the resulting fluorescent pyrene-labelled elastomers were studied by differential scanning calorimetry and dynamic mechanical analysis. No significant changes were observed in the thermal or mechanical properties of the elastomers containing pyrene when compared to otherwise identical samples not containing pyrene. All of the pyrene-containing elastomers were demonstrated to be fluorescent under suitable excitation in a photoluminescent spectrometer. Two of the elastomers were placed in a photoluminescence spectrometer and subjected to cycles of extension and relaxation (strain ¼ 0-16.7%) while changes in the emission spectra were monitored. The resulting spectra of the elastomer containing the PHMS-Py 50 copolymers were variable and inconsistent. However, the emission peaks of elastomers containing Py-TEOS displayed clear and reproducible changes in fluorescence intensity upon stretching and relaxation. The intensity of the monomer and excimer emission peaks was observed to increase with elongation of the sample and decrease upon relaxation. Furthermore, the ratio of the intensities of the excimer : monomer peak decreased with elongation and increased with relaxation. In neither case was there appreciable hysteresis, suggesting that fluorescent labelling of elastomers is a valid approach for the non-invasive in situ monitoring of stress and strain in such materials.
Reported here is the synthesis and subsequent characterization of the physical and chemical properties of novel polysiloxane elastomers modified with a series of polyhedraloligomericsilsequioxane (POSS) molecular silicas. The physical properties of the formulated nanocomposite systems have been characterized with a combination of dynamic mechanical analysis (DMA), broadband dielectric spectroscopy (BDS) and confocal Raman microscopy. The results of the physical property characterization demonstrate that the incorporation of low levels (1-4% by wt.) of POSS particles into the polysiloxane network leads to significant improvements in the mechanical properties of the elastomer and significantly alters the motional chain dynamics of the system as a whole. The results of studies performed to assess the long-term stability of these novel nanocomposite systems have demonstrated that POSS physical property modifiers can significantly alter the thermal stability of polysiloxane elastomers. Physically dispersed POSS has also been shown in some cases to be both mobile and disruptive within the polysiloxane networks, agglomerating into domains on a micron scale and migrating to the surface of the elastomers. This work demonstrates both the potential of POSS nanoparticles as physical property modifiers and describes the effects of POSS on the physical and chemical stability of polysiloxane systems.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.